Preliminary Single-Center Evaluation of the Alifax Molecular Mouse Sepsis Panel for Rapid Detection of Bloodstream Pathogens
Diagnostics · 28.07.2026 · 16 (15) · 2369
DOI: 10.3390/diagnostics16152369 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diagnostics, online erschienen am 28.07.2026. Verfasst von Jay Ho Han und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Uijeongbu St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Gyeonggi-do 11765, Republic …. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Trade, Industry and Energy, Hoilbiomed.
Themen: Sepsis
Abstract (Originalsprache)
Background/Objectives: We evaluated the diagnostic performance of the Alifax Molecular Mouse (MM) sepsis panel for rapidly directly detecting pathogens and resistance genes in positive blood culture broths.
Methods
In this prospective single-center study, 40 positive blood culture specimens were analyzed using four MM cartridges targeting Gram-positive and -negative bacteria and major antimicrobial resistance genes. The results were compared with those obtained using the routine microbiological protocol, including organism identification using the MALDI Biotyper system and antimicrobial susceptibility testing using the VITEK 2 and MicroScan WalkAway systems. Additionally, the MM panel results were compared with those obtained using the FilmArray BCID2.
Results
Compared with the routine protocol, the MM panel achieved a positive percent agreement (PPA) of 89.5% (34/38; 95% confidence interval [CI], 75.9–95.8%) for bacterial identification, indicating moderate-to-good diagnostic performance. For antimicrobial resistance gene detection, the PPA was 92.1% (35/38; 95% CI, 79.2–97.3%). Compared with the FilmArray BCID2, the overall agreement of the MM panel was 89.4% (34/38) for bacterial identification and 84.2% (32/38) for antimicrobial resistance gene detection. The MM panel generated clinically actionable results within 1 h (mean turnaround time, 55.5 min; 95% CI, 55.1–55.9 min), substantially reducing the turnaround time compared with the conventional microbiological workflow, which requires 1.5–2 days for subculture and automated antimicrobial susceptibility testing.
Conclusions
The MM sepsis panel enabled rapid, direct identification of bloodstream pathogens and key antimicrobial resistance markers from positive blood cultures, substantially reducing turnaround time and exhibiting its potential as an adjunct to routine microbiological workflows.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Laboratory Medicine, Uijeongbu St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Gyeonggi-do 11765, Republic of Korea.
- Department of Laboratory Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea.
- Department of Laboratory Medicine, Eunpyeong St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 03312, Republic of Korea.
ORCID-Profile: Jay Ho Han, Jae Kwon Kim, Sungjin Jo
Förderung
- Ministry of Trade, Industry and Energy
- Hoilbiomed
Zitieren
APA
Han, J. H., Kim, J. K., Kim, J. O., Lee, J. S., & Jo, S. (2026). Preliminary Single-Center Evaluation of the Alifax Molecular Mouse Sepsis Panel for Rapid Detection of Bloodstream Pathogens. Diagnostics, 16(15), 2369. https://doi.org/10.3390/diagnostics16152369
Vancouver
Han JH, Kim JK, Kim JO, Lee JS, Jo S. Preliminary Single-Center Evaluation of the Alifax Molecular Mouse Sepsis Panel for Rapid Detection of Bloodstream Pathogens. Diagnostics. 2026;16(15):2369. doi:10.3390/diagnostics16152369
BibTeX
@article{Han2026,
author = {Han, Jay Ho and Kim, Jae Kwon and Kim, Jung Ok and Lee, Jung Suk and Jo, Sungjin},
title = {Preliminary Single-Center Evaluation of the Alifax Molecular Mouse Sepsis Panel for Rapid Detection of Bloodstream Pathogens},
journal = {Diagnostics},
year = {2026},
volume = {16},
number = {15},
pages = {2369},
doi = {10.3390/diagnostics16152369}
}
EUVIMED